Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Conditions

Venous Thromboembolism 5Neoplasms 5Treatment of Venous Thromboembolism in Cancer Patients 3Pulmonary Embolism 2Venous Thrombosis 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Endometrial Neoplasms 1Embolism 1

Interventions

Rivaroxaban 2bemiparin 1apixaban 1Warfarin 1Tinzaparin 1Phenprocoumon 1Nephrectomy 1Nadroparin 1Heparin 1Fondaparinux 1Enoxaparin 1Drug Delivery Systems 1Dalteparin 1Dabigatran 1Aspirin 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Pulmonary Embolism × Rivaroxaban × Clear all
NCT02742623 2023-11-07

COSIMO

Bayer

Completed
528 enrolled

Neoplasms, Pulmonary Embolism, Venous Thrombosis

NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡